UNSPSC 51383313: Diclofenac hydroxyethylpyrrolidine

This classification denotes a cyclooxygenase inhibitor with the molecular formula C14H11Cl2NO2.C6H13NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X5F8EKL9ZG, chemically known as benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)-, compd. with 1-pyrrolidineethanol (1:1), but more generally known as diclofenac hydroxyethylpyrrolidine, which bears US NIH Compound Identifier 114753.

European Medicines Agency schedules diclofenac hydroxyethylpyrrolidine or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07092MIG. Most nations, for tariff purposes, schedule diclofenac hydroxyethylpyrrolidine under HS 29224995. SMILES: C1CCC(C(C1)CC(=O)O)NC2C(CCCC2CL)CL.C1CCN(C1)CCO.

UNSPSC 51383313 Diclofenac hydroxyethylpyrrolidine is a Commodity code that shows a significant mismatch between its nominal pharmaceutical scope and recent state and local activity. The single recent opportunity posted under this code — Seminole County, Florida's IFB60459723LAS for naloxone and drug deactivation systems — does not involve diclofenac or the anti-inflammatory drug class the code nominally describes. The procurement is instead for emergency overdose-reversal medication and safe medication disposal equipment, a public health supply category outside the code's stated product line. This suggests either a tagging error by the issuing jurisdiction or obsolescence of the code designation for this particular commodity family within state and local procurement workflows.

Seminole County, Florida posted the naloxone and drug deactivation systems IFB on June 30, 2026, with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually under a two-year initial term with a one-year renewal option. Quarterly deliveries are required to the Seminole County Community Health Building in Sanford, Florida. Vendors must include all shipping and delivery costs in their bids, maintain drug-free workplace certification and E-Verify compliance, and carry workers' compensation, commercial general liability, and professional liability insurance. The contract was potentially funded through FEMA, introducing additional federal compliance obligations including the Clean Air Act and Federal Water Pollution Control Act. Beyond this single opportunity, the code shows no recent state and local procurement activity that aligns with its pharmaceutical product description, limiting visibility into current demand or issuing-body patterns under the diclofenac classification.